US Stock MarketDetailed Quotes

Assembly Biosciences (ASMB)

Watchlist
  • 27.590
  • -0.030-0.11%
Trading Jan 23 10:38 ET
436.39MMarket Cap-6.00P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Assembly Biosciences (ASMB) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
0.73%-15.13M
2.01%-16.76M
-27.64%-23.44M
-324.76%-51.12M
-100.55%-407K
-10.08%-15.24M
-25.49%-17.1M
21.62%-18.36M
126.93%22.74M
482.50%73.65M
Net income from continuing operations
4.34%-9.2M
8.55%-10.2M
2.85%-8.82M
34.38%-40.18M
5.72%-10.34M
33.34%-9.61M
34.00%-11.15M
52.10%-9.08M
34.23%-61.23M
51.05%-10.96M
Operating gains losses
----
----
----
----
----
----
----
----
--139K
----
Depreciation and amortization
-3.03%32K
0.00%32K
3.13%33K
-71.33%129K
-61.90%32K
-71.55%33K
-74.60%32K
-74.19%32K
-9.64%450K
-32.26%84K
Other non cash items
-40.46%209K
-38.14%219K
-39.00%219K
-59.60%1.42M
-64.05%353K
-56.99%351K
-58.55%354K
-58.01%359K
0.06%3.51M
14.05%982K
Change In working capital
-20.87%-7.22M
-17.02%-7.27M
-64.72%-15.08M
-115.65%-11.95M
-88.76%9.39M
-405.16%-5.97M
-590.06%-6.21M
-26.42%-9.15M
3,697.60%76.34M
37,510.81%83.5M
-Change in receivables
---912K
----
----
-95.23%43K
--0
--0
-88.53%43K
--0
248.19%901K
-114.24%-43K
-Change in prepaid assets
-288.96%-856K
360.41%2.01M
-64.88%-1.08M
-92.03%73K
-371.43%-165K
1.57%453K
-79.22%437K
59.20%-652K
-31.02%916K
95.22%-35K
-Change in payables and accrued expense
503.39%4.63M
-73.20%558K
-96.94%-4.44M
145.03%2.63M
145.95%2.03M
188.57%767K
805.76%2.08M
59.08%-2.25M
-41,814.29%-5.84M
-2.82%827K
-Change in other current assets
----
----
----
--0
--0
--0
--0
--0
-29.12%577K
-66.85%240K
-Change in other current liabilities
42.20%-200K
11.76%-210K
68.47%-146K
62.90%-1.4M
66.51%-353K
60.86%-346K
74.07%-238K
49.56%-463K
-2.83%-3.77M
-14.19%-1.05M
-Change in other working capital
-44.30%-9.88M
-12.81%-9.63M
-62.82%-9.42M
-115.91%-13.29M
--7.87M
---6.85M
---8.53M
---5.79M
--83.56M
----
Cash from discontinued investing activities
Operating cash flow
0.73%-15.13M
2.01%-16.76M
-27.64%-23.44M
-324.76%-51.12M
-100.55%-407K
-10.08%-15.24M
-25.49%-17.1M
21.62%-18.36M
126.93%22.74M
482.50%73.65M
Investing cash flow
Cash flow from continuing investing activities
-746.32%-158.27M
232.76%16.99M
-61.87%6.59M
158.10%40.17M
92.53%-6.7M
29.70%24.49M
161.05%5.11M
72.72%17.27M
-176.28%-69.14M
-641.32%-89.65M
Net PPE purchase and sale
---42K
--0
--0
87.88%-28K
--0
--0
70.83%-14K
---14K
-126.47%-231K
---47K
Net investment purchase and sale
-746.15%-158.23M
231.85%16.99M
-61.90%6.59M
158.34%40.2M
92.53%-6.7M
28.77%24.49M
161.57%5.12M
72.86%17.29M
-177.21%-68.91M
-694.92%-89.61M
Cash from discontinued investing activities
Investing cash flow
-746.32%-158.27M
232.76%16.99M
-61.87%6.59M
158.10%40.17M
92.53%-6.7M
29.70%24.49M
161.05%5.11M
72.72%17.27M
-176.28%-69.14M
-641.32%-89.65M
Financing cash flow
Cash flow from continuing financing activities
171.93M
-97.13%357K
1.92M
113.12%29.45M
84.89%17M
0
9,194.03%12.45M
0
2,150.49%13.82M
2,003.43%9.19M
Net common stock issuance
--166.39M
--0
--1.92M
114.00%29.29M
84.83%16.9M
--0
22,853.70%12.4M
--0
4,112.00%13.69M
2,713.23%9.14M
Proceeds from stock option exercised by employees
--5.55M
----
----
20.16%155K
95.92%96K
--0
----
----
-55.36%129K
-56.25%49K
Cash from discontinued financing activities
Financing cash flow
--171.93M
-97.13%357K
--1.92M
113.12%29.45M
84.89%17M
--0
9,194.03%12.45M
--0
2,150.49%13.82M
2,003.43%9.19M
Net cash flow
Beginning cash position
24.98%24.01M
24.88%23.41M
93.26%38.34M
-62.15%19.84M
6.74%28.45M
-11.17%19.21M
-56.88%18.75M
-62.15%19.84M
14.88%52.42M
-51.24%26.66M
Current changes in cash
-115.92%-1.47M
29.19%593K
-1,267.31%-14.93M
156.80%18.5M
245.15%9.89M
83.67%9.24M
102.10%459K
87.78%-1.09M
-579.71%-32.58M
-202.22%-6.82M
End cash Position
-20.80%22.53M
24.98%24.01M
24.88%23.41M
93.26%38.34M
93.26%38.34M
6.74%28.45M
-11.17%19.21M
-56.88%18.75M
-62.15%19.84M
-62.15%19.84M
Free cash flow
0.45%-15.18M
2.09%-16.76M
-27.54%-23.44M
-327.43%-51.15M
-100.55%-407K
-9.01%-15.24M
-25.15%-17.12M
21.56%-18.38M
126.59%22.49M
482.13%73.58M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 0.73%-15.13M2.01%-16.76M-27.64%-23.44M-324.76%-51.12M-100.55%-407K-10.08%-15.24M-25.49%-17.1M21.62%-18.36M126.93%22.74M482.50%73.65M
Net income from continuing operations 4.34%-9.2M8.55%-10.2M2.85%-8.82M34.38%-40.18M5.72%-10.34M33.34%-9.61M34.00%-11.15M52.10%-9.08M34.23%-61.23M51.05%-10.96M
Operating gains losses ----------------------------------139K----
Depreciation and amortization -3.03%32K0.00%32K3.13%33K-71.33%129K-61.90%32K-71.55%33K-74.60%32K-74.19%32K-9.64%450K-32.26%84K
Other non cash items -40.46%209K-38.14%219K-39.00%219K-59.60%1.42M-64.05%353K-56.99%351K-58.55%354K-58.01%359K0.06%3.51M14.05%982K
Change In working capital -20.87%-7.22M-17.02%-7.27M-64.72%-15.08M-115.65%-11.95M-88.76%9.39M-405.16%-5.97M-590.06%-6.21M-26.42%-9.15M3,697.60%76.34M37,510.81%83.5M
-Change in receivables ---912K---------95.23%43K--0--0-88.53%43K--0248.19%901K-114.24%-43K
-Change in prepaid assets -288.96%-856K360.41%2.01M-64.88%-1.08M-92.03%73K-371.43%-165K1.57%453K-79.22%437K59.20%-652K-31.02%916K95.22%-35K
-Change in payables and accrued expense 503.39%4.63M-73.20%558K-96.94%-4.44M145.03%2.63M145.95%2.03M188.57%767K805.76%2.08M59.08%-2.25M-41,814.29%-5.84M-2.82%827K
-Change in other current assets --------------0--0--0--0--0-29.12%577K-66.85%240K
-Change in other current liabilities 42.20%-200K11.76%-210K68.47%-146K62.90%-1.4M66.51%-353K60.86%-346K74.07%-238K49.56%-463K-2.83%-3.77M-14.19%-1.05M
-Change in other working capital -44.30%-9.88M-12.81%-9.63M-62.82%-9.42M-115.91%-13.29M--7.87M---6.85M---8.53M---5.79M--83.56M----
Cash from discontinued investing activities
Operating cash flow 0.73%-15.13M2.01%-16.76M-27.64%-23.44M-324.76%-51.12M-100.55%-407K-10.08%-15.24M-25.49%-17.1M21.62%-18.36M126.93%22.74M482.50%73.65M
Investing cash flow
Cash flow from continuing investing activities -746.32%-158.27M232.76%16.99M-61.87%6.59M158.10%40.17M92.53%-6.7M29.70%24.49M161.05%5.11M72.72%17.27M-176.28%-69.14M-641.32%-89.65M
Net PPE purchase and sale ---42K--0--087.88%-28K--0--070.83%-14K---14K-126.47%-231K---47K
Net investment purchase and sale -746.15%-158.23M231.85%16.99M-61.90%6.59M158.34%40.2M92.53%-6.7M28.77%24.49M161.57%5.12M72.86%17.29M-177.21%-68.91M-694.92%-89.61M
Cash from discontinued investing activities
Investing cash flow -746.32%-158.27M232.76%16.99M-61.87%6.59M158.10%40.17M92.53%-6.7M29.70%24.49M161.05%5.11M72.72%17.27M-176.28%-69.14M-641.32%-89.65M
Financing cash flow
Cash flow from continuing financing activities 171.93M-97.13%357K1.92M113.12%29.45M84.89%17M09,194.03%12.45M02,150.49%13.82M2,003.43%9.19M
Net common stock issuance --166.39M--0--1.92M114.00%29.29M84.83%16.9M--022,853.70%12.4M--04,112.00%13.69M2,713.23%9.14M
Proceeds from stock option exercised by employees --5.55M--------20.16%155K95.92%96K--0---------55.36%129K-56.25%49K
Cash from discontinued financing activities
Financing cash flow --171.93M-97.13%357K--1.92M113.12%29.45M84.89%17M--09,194.03%12.45M--02,150.49%13.82M2,003.43%9.19M
Net cash flow
Beginning cash position 24.98%24.01M24.88%23.41M93.26%38.34M-62.15%19.84M6.74%28.45M-11.17%19.21M-56.88%18.75M-62.15%19.84M14.88%52.42M-51.24%26.66M
Current changes in cash -115.92%-1.47M29.19%593K-1,267.31%-14.93M156.80%18.5M245.15%9.89M83.67%9.24M102.10%459K87.78%-1.09M-579.71%-32.58M-202.22%-6.82M
End cash Position -20.80%22.53M24.98%24.01M24.88%23.41M93.26%38.34M93.26%38.34M6.74%28.45M-11.17%19.21M-56.88%18.75M-62.15%19.84M-62.15%19.84M
Free cash flow 0.45%-15.18M2.09%-16.76M-27.54%-23.44M-327.43%-51.15M-100.55%-407K-9.01%-15.24M-25.15%-17.12M21.56%-18.38M126.59%22.49M482.13%73.58M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +3.15%
Sample Name
Sample Code
 +2.78%
Sample Name
Sample Code
 +1.93%
4
Netflix
NFLX
+1.83%
5
NVIDIA
NVDA
+1.67%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +19.16%
Sample Name
Sample Code
 +8.74%
Sample Name
Sample Code
 +4.41%
4
KE Holdings
BEKE
+4.19%
5
H World Group
HTHT
+4.05%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -